US-backed hepatitis B vaccine trial on African newborns is halted
A US-backed hepatitis B vaccine trial on newborns in Guinea-Bissau will not go ahead. Lead researcher Frederik Schaltz-Buchholzer said the team did not get government approval. The study would have kept the vaccine from some babies, which experts called unethical. The CDC had pledged $1.6 million. On Monday, police searched the researchers' offices and seized vaccine doses.
Where this came from. 2 outlets reported this. We read them, then wrote the sixty words above.